A committee of MEPs will soon vote on proposals that could increase transparency of clinical trials. However, there are 350 lobbyists for the pharmaceutical industry at the European Parliament and MEPs are now hearing their arguments against transparency every day. We have until 29th May to make sure they hear our arguments.
The Environment, Public Health and Food Safety Committee of the European Parliament, which is made up of 67 MEPs from 22 countries, is currently scrutinising the Clinical Trials Regulation. On Wednesday 29th May they will vote on changes to the regulation. There are proposals on the table that could greatly increase clinical trial transparency and would mean that all clinical trials for medicines licensed in Europe would have to be registered and the results reported.
Click here for Email addresses and sample letters to write to MEPs
Rx Companies & the FDA – Gwen Olsen – the Rx Reformer
Gwen Olsen spent fifteen years as a very successful sales rep in the pharmaceutical industry working for health care giants including Johnson & Johnson, Syntex Labs, Bristol-Myers Squibb, Abbott Laboratories and Forest Laboratories. Now her new work is dedicated to the memory of her niece and her mission is to stop the over-medication of our children. Gwen is the author of Confessions of an Rx Drug Pusher and travels around the United States speaking to groups. In this video: Rx Companies & the FDA, Gwen sheds light on the relationship between the FDA and the major pharmaceutical companies.
We need to change the way miscarriage and pregnancy loss is handled outside of the medical community
“It is an event in my life that I will never forget. I woke up one morning and after four weeks of nausea, fatigue and strange cravings, I felt “normal,” which seemed wrong. Everyone reassured me there was no reason to worry. I’d seen a strong heartbeat at a six-week ultrasound, I’d had no cramping or bleeding, and it is normal for pregnancy symptoms to fluctuate. But I just knew in my gut something was wrong.”
A hysterectomy (removing the uterus) can be done via one of the four methods: vaginal, laparoscopic surgery, robotic surgery and abdominal hysterectomy.
The American Congress of Obstetricians and Gynecologists recommends vaginal hysterectomy as the least invasive method with the best outcomes.
Why are gynecologists pushing robotic hysterectomies?
Solo theater artist Alice Eve Cohen knew that childbearing was simply impossible – her own mother had taken DES, and Alice had a deformed uterus, among other disqualifiers. So when what doctors misdiagnosed as a tumor turned out to be a 6-month fetus, the 44-year-old Alice had to wrestle with clueless specialists, cavalier insurance companies, and her own no-see-um maternal instincts. A personal and medical odyssey beyond anything most women would believe possible.
” Exposure to estrogens during various stages of development has been shown to irreversibly influence responsive target organs. The recent finding of the presence of estrogen receptor in both osteoblasts and osteoclasts has suggested a direct role of steroid hormones on bone tissue. Furthermore, estrogens have important effects on bone turnover in both humans and experimental animal models. Thus, this tissue is now regarded as a specific estrogen target tissue. To investigate whether a short-term developmental exposure to estrogens can influence bone tissue, we have injected female mice with diethylstilbestrol (DES) from day 1 through day 5 of life. Additionally, a group of pregnant female mice were injected with different doses of DES from day 9 through 16 of pregnancy. Mice were then weaned at 21 days of age, and effects on bone tissue of the female mice were evaluated in adulthood (7-12 months of age). These short-term treatments did not affect body weight of exposed mice. However, a dose-dependent increase in bone mass, both in the trabecular and compact compartments, was observed in the DES-exposed female offspring. Furthermore, femurs from DES-exposed females were shorter than femurs from controls. A normal skeletal mineralization accompanied these changes in the bone tissue. In fact, a parallel increase in total calcium content of the skeleton was found in concomitance with the increase in bone mass. Estrogen treatment induced an increase in the amount of mineralized skeleton when compared to untreated controls. In summary, this report shows that alterations of estrogen levels during development can influence the early phases of bone tissue development inducing permanent changes in the skeleton. These changes appear to be related to bone cell programming in early phases of life. ”
This is the story of Gwen Olsen. She spent fifteen years as a very successful sales rep in the pharmaceutical industry working for health care giants including Johnson & Johnson, Syntex Labs, Bristol-Myers Squibb, Abbott Laboratories and Forest Laboratories. Now her new work is dedicated to the memory of her niece and her mission is to stop the over-medication of our children. Gwen is the author of Confessions of an Rx Drug Pusher and travels around the United States speaking to groups.
Even family doctors believe reproductive technology is more effective than it is, expert says
Judith Daniluk, a professor in clinical psychology at the University of British Columbia conducted a study that questioned 3,300 childless women across Canada last year. The results showed that 91 per cent of women believed that IVF could help most women have a baby using their own eggs up until menopause…
” When we think of prenatal drug disasters, we usually think of the sedative thalidomide, which caused horrific birth defects, and synthetic estrogen DES, which caused cancer and infertility in offspring, among other horrors.
Ignored, however, have been the downstream effects of the extensive use of progestin drugs in obstetric and fertility practice from the late 1950s through today. Progestins, not estrogens, were the most widely used anti-miscarriage drugs during several decades of practice that placed near-unquestioning faith in modern pharmaceuticals combined with near-nonexistent concern about impacts on the fetus. ”